Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
BDSX — Biodesix, Inc.
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 4, 2026
REVENUE
$25.6M -11.1%
NET MARGIN
-30.5% -16.7 PTS
EPS
-$0.81 -65.3%
FREE CASH FLOW
-$10.3M -1630.0%

No summary has been written for this call yet.